ACAT2 was shown to both promote and inhibit cancer progression, depending on the condition and specific setting; for example, its upregulation in gastric cancer increases the proliferation rate of the cancerous cells and the likelihood of metastasis [37]. Here, ACAT2 is linked to gastric cancer.